STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		6 Months Ended
	Mar. 31, 2013	Mar. 31, 2012	Mar. 31, 2013	Mar. 31, 2012
Income Statement [Abstract]
GRANT INCOME AND OTHER	$ 15,405	$ 106,543	$ 30,405	$ 111,567
OPERATING EXPENSES:
Research and development (excluding R&D depreciation of $55,957 and $108,531, respectively, included below)	2,515,585	2,594,235	0	0
Research and development (excluding R&D depreciation of $160,820 and $225,282, respectively, included below)	0	0	5,439,363	5,050,420
Depreciation and amortization	90,413	143,428	223,863	281,853
General & administrative	1,649,231	1,631,237	3,650,516	3,484,927
Total operating expenses	4,255,229	4,368,900	9,313,742	8,817,200
OPERATING LOSS	(4,239,824)	(4,262,357)	(9,283,337)	(8,705,633)
GAIN (LOSS) ON DERIVATIVE INSTRUMENTS	3,538,264	(4,204,327)	6,284,462	(3,247,857)
INTEREST INCOME	30,952	28,673	60,367	57,728
INTEREST EXPENSE	(42,763)	(55,948)	(85,109)	(179,410)
NET LOSS	(713,371)	(8,493,959)	(3,023,617)	(12,075,172)
ISSUANCE OF ADDITIONAL SHARES DUE TO RESET PROVISIONS	0	0	0	(250,000)
MODIFICATION OF WARRANTS	0	0	0	(325,620)
INDUCEMENT WARRANTS	0	(1,593,000)	0	(1,593,000)
NET LOSS AVAILABLE TO COMMON SHAREHOLDERS	$ (713,371)	$ (10,086,959)	$ (3,023,617)	$ (14,243,792)
NET LOSS PER COMMON SHARE
BASIC	$ 0.00	$ (0.04)	$ (0.01)	$ (0.06)
DILUTED	$ (0.01)	$ (0.04)	$ (0.03)	$ (0.06)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC	309,011,767	247,369,587	295,921,608	237,912,177
DILUTED	309,011,767	247,369,587	295,921,608	237,912,177